Biodesix, Inc.
Clinical trials sponsored by Biodesix, Inc., explained in plain language.
-
Blood test may take guesswork out of lung nodule decisions
Diagnosis OngoingThis study looks at whether a blood test called Nodify XL2 can help doctors better manage lung nodules that have a low to moderate chance of being cancer. About 2,000 adults over 40 with a solid lung nodule between 8 and 30 mm are taking part. The goal is to see if the test resul…
Sponsor: Biodesix, Inc. • Aim: Diagnosis
Last updated May 15, 2026 11:56 UTC
-
Blood test may help tailor lung cancer care
Knowledge-focused OngoingThis study looks at how doctors use the VeriStrat blood test to decide treatments for non-small cell lung cancer. About 5,000 patients are involved. The goal is to see if the test improves treatment choices and to explore new tests that might predict which medicines work best for…
Sponsor: Biodesix, Inc. • Aim: Knowledge-focused
Last updated May 06, 2026 16:15 UTC